granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change

issued from China Food and Drug Administration (CFDA) at the beginning of 2018 as the Company had to redesign its packaging to comply with the requirements of the license and adjust its sales structures

this year, consequently, there was expenses related to the overseas travelling and other administration fees and (4) Decrease in tax and penalties due to the Company incurred tax and penalties provision

commission expense from Hi Healthcare center Co., Ltd. for improve sale and service. 3.4 Administration expenses The Group's administrative expense was increased from the year 2018 in an amounting of Baht

Co., Ltd. was decreased from Wuttisak Clinic was temporary closed from COVID - 19. 3.4 Administration expenses The Group's administrative expense was decreased from the same period of previous year in

same period of 2021. Administrative Expenses In the 1st quarter of 2021, administration costs were THB 95.1 Mn, a decrease of THB 17.0 Mn or 15.2% from the same period of 2020. This decrease was mainly

the year 2019 in an amounting of Baht (3.87) million or (10.39) percent. Mainly came from growth of revenue in last year while fixed cost still constant. 3.3 Administration expenses The Group's

cost structure products. Selling and Administration Expenses • Selling expenses to total revenue ratio rose by 0.28% YoY resulting primarily from decreasing in total revenue. • Administrative expenses to

/impairment of asset, etc. Administrative expenses in 2018 was 1,599 million Baht increased by 59% YoY mainly due to higher personnel expenses reflecting increased number of employees and administration of the

 Privacy Policy Personal Data Protection Policy for Internal Administration (Website) The Office of the Securities and Exchange Commission (SEC Office) 0. Scope of this Policy This Personal Data